Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 9 min ago

EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)

Mon, 08/11/2014 - 12:38
TARRYTOWN, N.Y., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual imp...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept, Diabetic Macular Edema

Karyopharm Appoints Justin Renz Executive Vice President and Chief Financial Officer

Fri, 08/08/2014 - 12:42
NEWTON, Mass., Aug. 8, 2014 -- (Healthcare Sales & Marketing Network) -- Karyopharm Therapeutics Inc. (KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport ...
Biopharmaceuticals, Personnel
Karyopharm Therapeutics, Selinexor

Specialty Vaccine Company PaxVax Expands Global Commercial Team

Thu, 08/07/2014 - 15:10
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the expansion of its global commercial team with the appointments of Jonathan Klock as Vice President ...
Biopharmaceuticals, Personnel
PaxVax, vaccine, Vivotif, typhoid, cholera, anthrax

Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization

Thu, 08/07/2014 - 15:07
Veteran Medical Device Executive with Expertise in Clinical, Reimbursement, Sales, Marketing REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive so...
Devices, Personnel
Gynesonics, uterine fibroids, VizAblate

OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer

Thu, 08/07/2014 - 15:00
BOTHELL, Wash. and VANCOUVER, British Columbia , Aug. 7, 2014 (Healthcare Sales & Marketing Network) -- OncoGenex Pharmaceuticals, Inc. (OGXI) today announced the appointment of John A. Bencich as Vice President and Chief Financial Officer (CFO). John B...
Biopharmaceuticals, Oncology, Personnel
OncoGenex Pharmaceuticals, custirsen, prostate cancer

Cortendo Appoints Matthew Pauls as Chief Executive Officer

Thu, 08/07/2014 - 14:57
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--Cortendo AB (OSE:CORT) announces the appointment of Matthew Pauls as President and Chief Executive Officer effective Monday, August 25, 2014. Mr. Pauls brings to Cortendo more than 20 years ...
Biopharmaceuticals, Endocrinology, Personnel
Cortendo, NormoCort, cortisol, Cushing’s Syndrome

BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes

Wed, 08/06/2014 - 15:20
The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection FRANKLIN LAKES, N.J., Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- BD Medical, a segment of BD (Becton,...
Devices, Drug Delivery, Endocrinology, Product Launch
BD , AutoShield, needle, diabetes

Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer

Wed, 08/06/2014 - 15:15
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Nodality, Inc., an innovative biotechnology company advancing discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology an...
Biopharmaceuticals, Personnel
Nodality, Single Cell Network Profiling

Tufts Medical Center and ATON Partners Announce Formation of CereVasc, LLC

Wed, 08/06/2014 - 12:23
Development Stage Company to Focus on Breakthrough Treatments of Neurological Diseases BOSTON, Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Tufts Medical Center and ATON Partners, LLC today announced the formation of CereVasc, LLC, a rese...
Devices, Neurosurgery
ATON Partners, CereVasc , hydrocephalus

Synta Names Anne Whitaker Chief Executive Officer

Wed, 08/06/2014 - 12:16
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Synta Pharmaceuticals Corp. (SNTA) today announced that Anne Whitaker will join the Company as President, Chief Executive Officer and a member of the Company’s Board of Directors effective September...
Biopharmaceuticals, Personnel
Synta Pharmaceuticals

Akebia Therapeutics Announces Expansion of Management Team

Wed, 08/06/2014 - 12:13
Key additions will help drive strategic growth and advance lead clinical programs CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-indu...
Biopharmaceuticals, Personnel
Akebia Therapeutics, hypoxia-inducible factor

FDA Approves the SynCardia Total Artificial Heart With SynHall Valves

Tue, 08/05/2014 - 17:01
SynCardia Systems, Inc., now controls last key component in heart manufacturing TUCSON, Ariz., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administ...
Devices, Cardiology, FDA
SynCardia Systems, Total Artificial Heart, SynHall valve

IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery

Tue, 08/05/2014 - 16:57
100% Local (Resection Cavity) Freedom From Progression With 19.3 Month Median Follow-Up RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radi...
Devices, Neurosurgery, Oncology
IsoRay, Cesium-131, brachytherapy, brain cancer, radiotherapy

EDAP Comments on FDA Panel Vote

Tue, 08/05/2014 - 16:52
Responds to Gastroenterology and Urology Devices Panel Vote on Ablatherm-HIFU for Treatment of Prostate Cancer LYON, France, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today...
Devices, Oncology, FDA
EDAP TMS, Ablatherm, high-intensity focused ultrasound, prostate cancer

CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment

Tue, 08/05/2014 - 16:48
St. Jude Medical’s CardioMEMS HF System demonstrates our commitment to delivering high-quality, innovative solutions that reduce health care costs and improve outcomes for patients ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medic...
Devices, Cardiology, Reimbursement
St. Jude Medical, CardioMEMS, pulmonary artery pressure

Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors

Tue, 08/05/2014 - 16:44
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Dire...
Biopharmaceuticals, Neurology, Personnel
Alzheon, ALZ-801, Alzheimer’s disease

MELA Sciences Names Michael R. Stewart to Board of Directors

Tue, 08/05/2014 - 16:41
Stewart Brings to MELA a Wealth of Dermatological Medical Device Expertise Across All Aspects of the Business IRVINGTON, N.Y., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- MELA Sciences, Inc. (MELA), developer of the MelaFind(R) system, an ...
Devices, Diagnostics, Oncology, Dermatology, Personnel
MELA Sciences, MelaFind, melanoma

Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

Tue, 08/05/2014 - 12:25
QUÉBEC CITY, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC, ("ASCEND...
Biopharmaceuticals, Distribution
Aeterna Zentaris, ASCEND Therapeutics, EstroGel, Macrilen

Boston Therapeutics Expands Medical Advisory Board

Tue, 08/05/2014 - 12:20
Noted Diabetes Experts Meng H Tan, M.D., Philip Raskin, M.D., and Charles M. Clark, Jr., M.D. to Serve as Medical Advisory Board Members MANCHESTER, NH--(Healthcare Sales & Marketing Network)) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Ther...
Biopharmaceuticals, Personnel
Boston Therapeutics

TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer

Tue, 08/05/2014 - 12:15
MENLO PARK, Calif., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- TesoRx Pharma, LLC., a specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has cl...
Biopharmaceuticals, Personnel, Venture Capital
TesoRx Pharma

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong